PDL BioPharma, Inc. Revenue per Share

Revenue per Share of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue per Share growth rates and interactive chart. Calculated as total revenue divided by the number of weighted average shares outstanding in the period. It can be easily compared to the stock price to determine how revenue is an investor getting for every $1 paid for a stock.


Highlights and Quick Summary

  • Revenue per Share for the quarter ending June 29, 2020 was 0.05 (a -7.79% decrease compared to previous quarter)
  • Year-over-year quarterly Revenue per Share decreased by -88.49%
  • Annual Revenue per Share for 2019 was 0.46 (a -66.06% decrease from previous year)
  • Annual Revenue per Share for 2018 was 1.36 (a -33.97% decrease from previous year)
  • Annual Revenue per Share for 2017 was 2.06 (a 38.11% increase from previous year)
  • Twelve month Revenue per Share ending June 29, 2020 was 0.45 (a 1.61% increase compared to previous quarter)
  • Twelve month trailing Revenue per Share decreased by -51.17% year-over-year
Trailing Revenue per Share for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
0.45 0.44 0.46 0.92
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue per Share of PDL BioPharma, Inc.

Most recent Revenue per Shareof PDLI including historical data for past 10 years.

Interactive Chart of Revenue per Share of PDL BioPharma, Inc.

PDL BioPharma, Inc. Revenue per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 0.05 0.05
2019 -0.03 0.39 0.06 0.05 0.46
2018 0.31 0.47 0.32 0.25 1.36
2017 0.44 0.42 0.92 0.28 2.06
2016 0.41 0.33 0.13 0.63 1.49
2015 1.09 0.76 0.84 0.92 3.61
2014 0.74 1.03 1.02 0.9 3.67
2013 0.83 0.72 1.06 0.66 3.26
2012 0.66 0.61 0.9 0.55 2.73
2011 0.52 0.6 0.87 0.6 2.59
2010 0.6 0.68 1.01 2.73

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.